Related Experiment Video
Updated: May 18, 2026

A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats
Published on: March 1, 2022
Sildenafil (viagra) and the heart
1King Fahd Armed Forces Hospital, Jeddah, Saudi Arabia.
Sildenafil is an effective oral treatment for erectile dysfunction, but carries risks. Patients must receive clear instructions, especially regarding contraindications with nitrates due to potential fatal hypotension.
Area of Science:
- Pharmacology
- Urology
- Cardiology
Background:
- Erectile dysfunction (ED) is a common condition affecting many men.
- Oral pharmacotherapies are a primary treatment modality for ED.
- Sildenafil is a widely prescribed medication for ED.
Purpose of the Study:
- To summarize the efficacy and safety profile of sildenafil for erectile dysfunction.
- To highlight critical patient instructions and contraindications for sildenafil use.
Main Methods:
- Review of clinical data and prescribing information for sildenafil.
- Analysis of common side effects and drug interactions.
- Identification of patient populations for whom sildenafil is contraindicated.
Main Results:
- Sildenafil is the most effective oral therapy for ED.
- Common side effects include flushing, headaches, dyspepsia, and visual disturbances.
- Fatal hypotension can occur when combined with nitrates; co-administration is contraindicated.
- Sildenafil is not recommended for patients with low cardiac output, heart failure regimens, or acute coronary ischemia.
Conclusions:
- Sildenafil offers significant efficacy for ED treatment.
- Clear patient counseling on administration and contraindications, particularly with nitrates, is essential for safe use.
- Careful patient selection is crucial to minimize adverse events.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Heart Failure Drugs: β-Blockers
Cardiovascular Drugs: Classification based on Therapeutic Indications
Antihypertensive Drugs: Vasodilators
Heart Failure V: Medical Management
